deListed Australia
 
SEARCH LISTED OR DELISTED COMPANY
Any AUS or NZ company

Browse Australian delisted companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse terminated Australian managed funds

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
SEARCH PRIVATE COMPANY
SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

OSPREY MEDICAL INC (ASX.OSP)

ASX Announcements (courtesy of ASX)

20122013201420152016201720182019202020212022

ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)
Former (or subsequent) names

 

Shareholder links
Our website ranking of OSP: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details
ISIN: AU000000OSP4
Address: Level 13, 41 Exhibitions Street, Melbourne, Victoria, 3000
Tel:  0410 442 393 Fax: (03) 9663 6609

Date first listed: 02/05/2012

Sector: Health Care Equipment & Services
Industry Group: XHJ
Activities: Development and commercialization of its proprietary CINCOR System, a medical device used for the prevention of Contrast Induced Nephropathy (CIN)

company is deregistered today

17/01/2023

Strike-Off Action In Progress

30/10/2022

delisted following failure to pay the annual ASX listing fees per Listing Rule 17.15

29/08/2022

we understand the company failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023

29/08/2022

Under Listing Rule 17.6, an entity (if not already suspended) that had not paid its annual listing fees by close of business on Friday, 19 August 2022 would have its securities suspended from Official Quotation before the commencement of trading on Monday, 22 August 2022. The following entity has failed to pay to ASX Limited the annual listing fees for the year ending 30 June 2023, and each entity's securities are already suspended from quotation. Under Listing Rule 17.15, any entity that has not paid its annual listing fees as required by Listing Rule 16.5 by 5.00 pm AEST on Friday, 26 August 2022 will be removed from the Official List with effect from the close of trading on Friday, 26 August 2022.

22/08/2022

The company lodges its Quarterly Activities/Appendix 4C Cash Flow Report.

29/07/2022

The Company is working with creditors and other stakeholders to reduce the Company's debt and gain access to new sources of liquidity. Cash from ongoing operations is expected to provide sufficient liquidity to support Osprey's continuing business operations and minimise disruption to customers until completion of the restructure of Osprey's business in CY 2023. The Company expects that its shares will remain suspended from trading until at least completion of the business restructure.

01/06/2022

The company has postponed the AGM scheduled for 2 June 2022 until further notice.

26/05/2022

The company is continuing its suspension from trading in order to provide Osprey with additional time to complete its consideration of the options available to it and to provide the market with an accurate update on next steps. The suspension will continue for a period of up to 16 trading days; and the suspension will end upon the release of an announcement by Osprey in connection with its review of options.

10/05/2022

The company is reducing its workforce across all areas effective this Friday (US time). The company continues to assess next steps and expects to update the market shortly on further developments.

06/05/2022

The securities of Osprey Medical Inc. will be suspended from quotation immediately under Listing Rule 17.2, at the request of OSP, pending the release of an announcement regarding its strategic and funding options.

03/05/2022

The securities of Osprey Medical Inc (the "Company") will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: OSP

23/03/2015

The securities of Osprey Medical Inc (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the company. Security Code: OSP

19/03/2015

listed entity carried for record purposes only

02/05/2012
View ASX Announcements (courtesy of ASX)

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates
Post your comments here
Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    loading Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    04/03/2019Neville Mitchell185,809$0.110$20,362
    06/06/2018Neville Mitchell250,000$0.150$37,500
    15/05/2018Neville Mitchell250,000$0.190$47,500
    17/05/2016Neville MitchellOn market CDI100,000$0.252$25,180
    16/05/2014Neville MitchellOn market CDI50,000$0.541$27,061

    Click here for the last 20 transactions all companies

    Directors & Executives (current)
    NAMETITLEDATE OF APPT
    John ErbNon Exec Chairman02/05/2012
    Mike McCormickPresident, CEO02/05/2012
    Chris NaveNon Exec Director02/05/2012
    Martin EmersonDirector12/08/2021
    Steven BrandtDirector01/07/2021
    Brendan CaseCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)
    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Neville MitchellDirector03/07/201226/05/2022
    Sandra LesenfantsNon Exec Director20/06/201725/05/2022
    Andy JaneDirector13/11/201218/08/2020
    Mark HarveyNon Exec Director02/05/201213/11/2012

    Date of first appointment, title may have changed.